Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer

Thoracic and Cardiovascular Surgeon

Volumn 58, Issue 6, 2010, Pages 345-349

  Takamochi, K ^a   Oh, S ^a   Suzuki, K ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

lung cancer; lymph node; staging

Indexed keywords

ADULT; AGED; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956669890     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0030-1249944     Document Type: Review

References (23)

1. Mountain C F. Revisions in the international system for staging lung cancer. Chest 1997 111 1710-1717
2. Sobin L, Wittekind C. International Union Against Cancer (UICC): TNM classification of malignant tumors. 6th ed. New York John Wiley & Sons 2002
3. Goldstraw P. Staging manual in thoracic oncology. Orange Park, FL, USA Editorial Rx Press 2009
4. Rusch V W., Crowley J, Giroux D J. et al. The IASLC lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007 2 603-612 (Pubitemid 47171781)
5. Naruke T. [The spread of lung cancer and its relevance to lung surgery]. Nippon Kyobu Geka Gakkai Zasshi 1967 68 1607-1621
6. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978 76 832-839
7. Mountain C F., Dresler C M. Regional lymph node classification for lung cancer staging. Chest 1997 111 1718-1723
8. Rusch V W., Asamura H, Watanabe H et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009 4 568-577
9. Sakao Y, Miyamoto H, Oh S, Takahashi N, Sakuraba M. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement. J Thorac Oncol 2007 2 1107-1111
10. Sakao Y, Miyamoto H, Yamazaki A et al. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. Eur J Cardiothorac Surg 2006 30 543-547
11. World Health Organization. Histological typing of lung and pleural tumours. 3rd ed. Geneva World Health Organization 1999
12. Goldstraw P, Crowley J, Chansky K et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007 2 706-714 (Pubitemid 47357522)
13. Demir A, Turna A, Kocaturk C et al. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Ann Thorac Surg 2009 87 1014-1022
14. Andre F, Grunenwald D, Pignon J P. et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000 18 2981-2989
15. Okada M, Sakamoto T, Yuki T et al. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg 2005 129 825-830
16. Fukui T, Mori S, Yokoi K, Mitsudomi T. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 2006 1 120-125
17. Keller S M., Vangel M G., Wagner H et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 2004 128 130-137
18. Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg 2008 86 1626-1630
19. Prenzel K L., Baldus S E., Monig S P. et al. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes. Cancer 2004 100 1909-1917
20. Riquet M, Assouad J, Bagan P et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 2005 79 225-233
21. Tsubota N, Yoshimura M. Skip metastasis and hidden N2 disease in lung cancer: how successful is mediastinal dissection? Surg Today 1996 26 169-172
22. Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults. J Thorac Cardiovasc Surg 1989 97 623-632
23. Lardinois D, De Leyn P, Van Schil P et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006 30 787-792